Abstract: A separation string includes an outer pre-drilled liner and an inner assembly disposed within the outer pre-drilled liner. The inner assembly includes a shear-out member and a filter assembly for separating hydrocarbons from contaminants. A swivel slack joint is connected to an upper end of the inner assembly to facilitate mounting of a top sub to the inner assembly and to the outer pre-drilled liner without producing rotation of the inner assembly. The swivel slack joint includes an outer sleeve connected to the inner assembly, and a tube connected to the top sub. The tube is freely rotatable and vertically slidable relative to the sleeve. The shear-out member is designed to shear at a load less than a load which would cause other components of the inner assembly to shear, and to present, upon shearing, a portion configured to be grasped by a retrieval tool.

Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective &bgr;3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity.

Abstract: The present invention provides for a sign consisting of an alloy substrate encapsulated in a porcelain coating which can be selectively applied to different areas of the substrate. The coating provides a smooth transitional region on graphic indicia of the sign to make the sign impervious to vandalism, fire and dirt. There is also provided a process of selectively applying a second coat of porcelain to the existing coating to only those elevated portions elevated or Braille portions of the substrate.

Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity.

Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity.

Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and method of treating type II diabetes, comprising administering to a mammal in need thereof compounds of the Formula II: ##STR1## The variables in Formula II are defined herein.

Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and method of treating type II diabetes, comprising administering to a mammal in need thereof compounds of the Formula II: ##STR1## The variables in Formula II are defined herein.

Abstract: The present invention provides for a sign consisting of an alloy substrate encapsulated in a porcelain coating which can be selectively applied to different areas of the substrate. The coating provides a smooth transitional region on graphic indicia of the sign to make the sign impervious to vandalism, fire and dirt. There is also provided a process of selectively applying a second coat of porcelain to the existing coating to only those elevated portions elevated or Braille portions of the substrate.

Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity.

Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity.

Abstract: A conveyor belt comprising a series of belt links arranged in superimposed successive overlapping relation secured together by interlocking belt link fasteners and apertures, combined with heat protection barriers to protect the belt from contacting high temperature materials that are transported. The barriers interlock with the links of the belt forming a surface which contacts the high temperature materials.

Abstract: Liquid textile treatment compositions in the form of isotropic solutions comprising water-insoluble di-C.sub.16 -C.sub.24 optionally hydroxy-substituted alkyl, alkaryl or alkenyl cationic fabric softener, at least about 70% of the fabric softener consisting of one or more components together having a melting completion temperature of less than about 20.degree. C., a water-insoluble nonionic extender, especially C.sub.10 -C.sub.40 hydrocarbons or esters of mono- or polyhydric alcohols with C.sub.8 -C.sub.24 fatty acids, and a water-miscible organic solvent. The concentrates have improved formulation stability and dispersibility combined with excellent fabric softening characteristics.